These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2828264)

  • 1. Ganglionic permissivity to HSV-1 replication and acyclovir-induced latency: an in vitro model.
    Millin JA; Opremcak EM; Wells PA; Foster CS
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):232-8. PubMed ID: 2828264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of HSV-1 infection in trigeminal ganglion cells. An in vitro model of latency.
    Dunkel EC; Green MT; Rosborough JP
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):525-33. PubMed ID: 6325365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of murine latent HSV infection by epinephrine iontophoresis.
    Willey DE; Trousdale MD; Nesburn AB
    Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):945-50. PubMed ID: 6086546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice.
    Abghari SZ; Stulting RD
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):239-43. PubMed ID: 2828265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timolol promotes reactivation of latent HSV-1 in the mouse iontophoresis model.
    Harwick J; Romanowski E; Araullo-Cruz T; Gordon YJ
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):580-4. PubMed ID: 3030958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of HSV and establishment of latency after corneal infection in inbred mice.
    Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ
    Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):77-82. PubMed ID: 3000975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
    Sekizawa T; Openshaw H; Itoyama Y
    J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of acyclovir-induced suppression of HSV-1 replication in rabbit corneal cells.
    Rong BL; Dunkel EC; Pavan-Langston D
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):928-32. PubMed ID: 2836333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
    Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
    Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
    Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.
    Sawtell NM; Bernstein DI; Stanberry LR
    J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrieval of latent herpes simplex virus type 1 genetic information from murine trigeminal ganglia by superinfection with heterotypic virus in vivo.
    Thomas E; Lycke E; Vahlne A
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1763-70. PubMed ID: 2991439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
    Gebhardt BM; Kaufman HE; Hill JM
    Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency.
    Gordon YJ; Araullo-Cruz TP; Romanowski E; Ruziczka L; Balouris C; Oren J; Cheng KP; Kim S
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1230-4. PubMed ID: 3015823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide modulation of herpes simplex virus latency and reactivation.
    Sainz de la Maza M; Wells PA; Foster CS
    Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2154-9. PubMed ID: 2551836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.